The study, which involved more than 32,000 participants, found that the vaccine was 79% effective at preventing symptomatic COVID-19 and 100% effective at preventing severe
The study, which involved more than 32,000 participants, found that the vaccine was 79% effective at preventing symptomatic COVID-19 and 100% effective at preventing severe